Impact of Discontinuing Contact Precautions for Extended-spectrum β-lactamase Enterobacteriaceae in a Geriatric Unit
Recruiting now · Not applicable
Conditions studied: Infection, Hospital
In brief
This is an interventional multicenter prospective noninferiority non-randomized double-blind controlled before and after study. The aim of this study is to demonstrate that standard precautions alone are not inferior to contact precautions by comparing the incidence density of extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae acquired in geriatric units before and after discontinuing contact precautions.
Key facts
- Study ID
- NCT05475574
- Run by
- Centre Hospitalier Régional Metz-Thionville
- People needed
- 954
- Starts
- 2023-03-07
- Expected to finish
- 2029-09-21
- Last updated by the study team
- 2026-06-24
Who can join
Age: 65 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adult patient (> 65 years old)
- Patient hospitalized in geriatrics during the study period
- Free and informed consent obtained from the patient (or his trusted person or legal representative) within 48 hours of its admission at the geriatric unit
- Patient affiliated to a social security scheme
- Non Inclusion Criteria:
- Patient requiring contact precaution for an indication other than ESBLE (COVID-19, classical PCC excluding EBLSE, Clostridium difficile PCC, scabies PCC and BHRe PCC) on admission
- Patient under legal protection
- Person deprived of liberty
You may not qualify if…
- Patient requiring contact precaution for an indication other than ESBL during the patient stay (COVID-19, classical PCC excluding EBLSE, Clostridium difficile PCC, scabies PCC and BHRe PCC)
- Patient's stay period less than 4 days
Where it is running
- CHR Metz-Thionville/Hôpital Bel Air — Metz, France (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.